Quick Summary: Mukka Proteins Limited has completed the acquisition of a majority 51% stake in FABBCO Bio Cycle and Bio Protein Technology Pvt. Ltd. for ₹5.95 crore, marking its entry into the insect protein and animal feed sector.
Full Article: Mukka Proteins Limited has announced the completion of its strategic investment in FABBCO Bio Cycle and Bio Protein Technology Private Limited (FABBCO). The company acquired and subscribed to 4,858 equity shares of FABBCO, representing 51% of its issued and paid-up capital, for a total cash consideration of ₹5.95 crore.
With this acquisition, FABBCO has become a subsidiary of Mukka Proteins. The investment aligns with the company’s long-term strategy to expand its insect protein business, which is expected to contribute to sustainable growth.
FABBCO, incorporated in June 2023, is engaged in the manufacturing of animal feed and processing of various types of waste. For FY 2023–24, the company reported a turnover of ₹77.97 lakh and a loss of ₹53.25 lakh.
The acquisition was completed on September 2, 2025, and did not require any regulatory approvals. The transaction involved both subscription to new shares and purchase of equity shares from existing shareholders at a premium of ₹11,250 per share over the face value of ₹1,000.
Mukka Proteins stated that this move is part of its broader strategy to strengthen its portfolio and enter new segments of sustainable protein production.